Health

India’s Covaxin Found To Offer 77.8 Percent Protection Against COVID-19: Study

GENEVA, Nov 12 — Data from Phase 3 trials of the coronavirus vaccine Covaxin, developed in India, has shown that two doses offer 77.8 per cent protection against COVID-19, according to findings published Thursday in The Lancet medical journal.

Covaxin, known by the code BBV152, is an inactivated virus-based COVID-19 vaccine developed by Bharat Biotech in collaboration with the Indian Council of Medical Research and National Institute of Virology.

The drug on Nov 3 was granted emergency use approval by the World Health Organisation (WHO) for adults 18 years and older and is the eighth jab to be given the green light by the health body.

The WHO determined that Covaxin met its standards for protection against COVID-19 and “that the benefit of the vaccine far outweighs risks.”

It recommended the vaccine be administered in two doses, with an interval of four weeks in age groups 18 and above, reported Anadolu Agency.

The jab has not been advised for pregnant women as available data is “insufficient” to “assess vaccine safety or efficacy in pregnancy.”

Other COVID-19 vaccines approved by the specialised UN agency are Pfizer-BioNTech, Oxford-AstraZeneca, Johnson & Johnson’s Janssen, Moderna, Sinopharm, and Sinovac.

The Phase 3 trials ran from Nov 16, 2020 until May 17, 2021, and included participants between 18 and 97 years old, said the article in the scientific journal.

Trial participants were given two doses of either Covaxin or a placebo.

Participants considered at high risk for COVID-19 infection were prioritised, with 2,750 participants above 60 years of age and 5,724 participants with at least one preexisting condition included in the study.

Participants were recruited from 25 hospitals across India for geographic diversity.

Covaxin “was well-tolerated by all trial participants; 12 per cent of both groups reported an adverse event, with no significant difference in the number of events between the placebo and BBV152 groups,” said the findings.

Sources: BERNAMA

Adib Mohd

Recent Posts

NakNak’s Bold Bulgogi Series: Big Flavours, Korean Vibes & A Side of Curly Fries

Homegrown quick service restaurant brand NakNak is turning up the flavour this season with the… Read More

7 hours ago

Eco-Shop Ushers in Merdeka Spirit with Nationwide “Satu Senyuman, Seribu Makna” Campaign

Eco-Shop, Malaysia’s Leading Ultra Affordable Household Retailer, is calling on Malaysians to rediscover the beauty… Read More

10 hours ago

Stephen Curry Takes Curry Camp Global, First Stop, Asia!

Stephen Curry is going global. For the first time ever, his iconic Curry Camp is… Read More

10 hours ago

Charge Fast, Stay Cool, Live Free CUKTECH Celebrates Merdeka with Pocket-Sized Power Tools

Say hello to hassle-free charging, cool commutes, and gadgets that just work, anytime, anywhere. The… Read More

10 hours ago

‘negaraku II’ Unpacks the Real Malaysian Experience Through Art

What does it really mean to call yourself Malaysian? That’s the question at the heart… Read More

10 hours ago

Batik Air Joins Forces with UAE’s ESSAD, Boost Malaysian Tourism Ahead of Visit Malaysia 2026

In a strategic push to position Malaysia as a must-visit destination for Middle Eastern travellers,… Read More

13 hours ago

This website uses cookies.